Effect of blood pressure lowering on markers of kidney disease progression
- First Online:
- Cite this article as:
- Udani, S.M. & Koyner, J.L. Current Science Inc (2009) 11: 368. doi:10.1007/s11906-009-0061-2
- 88 Downloads
Hypertension remains a common comorbidity and cause of chronic kidney disease (CKD). As the number of patients with CKD grows, so does the need to identify modifiable risk factors for CKD progression. Data on slowing progression of CKD or preventing end-stage renal disease with aggressive blood pressure control have not yielded definitive conclusions regarding ideal blood pressure targets. Shifting the focus of antihypertensive therapy to alternative markers of end-organ damage, specifically proteinuria, has yielded some promise in preventing the progression of CKD. Nevertheless, proteinuria and decline in estimated GFR may represent an irreversible degree of injury to the kidney that limits the impact of any therapy. The identification and use of novel markers of kidney injury to assess the impact of antihyper tensive therapy may yield clearer direction with regard to optimal management of hypertension in the setting of CKD.